Log In
Print
BCIQ
Print
Print this Print this
 

BIOD-123

  Manage Alerts
Collapse Summary General Information
Company Biodel Inc.
DescriptionUltra rapid-acting formulation of recombinant human insulin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today